BCR and diffuse large B-cell lymphoma: Activated BCR signaling has been suggested as a critical growth pathway in MCL, diffuse large B-cell lymphoma (DLBCL), follicular lymphoma, and B-cell chronic lymphocytic leukemia (CLL) [12–14].